Extendicare Inc (EXE.TO) is facing a notable decline in stock performance this week amid recent corporate activities.
This week, Extendicare Inc has seen a significant drop in its stock price, reflecting broader market sentiments and recent corporate developments. As the health care sector evolves, investors are closely watching Extendicare's strategic moves.
Investor takeaway: While Extendicare's recent adjustments in its portfolio and financial restructuring may offer long-term growth potential, the immediate market reactions show caution among investors. Keeping an eye on the company's financial health and market positioning will be crucial for potential investors.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
WealthAwesomeMarket cap
$3.48B
P/E
26.1x
Div. yield
1.39%
Div. / share
$0.51
52W high
$39.09
52W low
$12.09
1W change
-10.13%
Beta
1.16
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 12.5% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$38.83
+12.5% Upside
Current Price
C$34.51
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
29.9%
Annualized
90-Day Vol
34.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$41.26
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$36.63 | C$33.04 – C$40.61 |
| 60 trading days | C$38.87 | C$33.60 – C$44.98 |
| 90 trading days | C$41.26 | C$34.51 – C$49.33 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
C$34.91: Current price of Extendicare Inc stock.
The stock's current P/E ratio of 26.09 indicates a premium valuation compared to the market, suggesting that investors expect future growth.
Bull case
Extendicare's recent acquisitions and positive adjusted EBITDA growth suggest a strong operational strategy that could improve its market position in the health care sector.
Bear case
The recent stock decline and high beta indicate that Extendicare may be more volatile compared to the broader market, which could raise concerns for risk-averse investors.
Price Action
Advertisement
Extendicare Inc's stock closed at C$34.91, down 2.73% on the day. Over the past week, the stock has declined by 10.13%, raising questions about market sentiment and investor confidence.
Recent Corporate Developments
Although there were no major announcements this week, recent headlines have highlighted significant corporate activities for Extendicare. The company has completed a $450 million senior unsecured notes offering to refinance existing debt, which could strengthen its financial position. Additionally, their acquisition of CBI Home Health for $570 million is expected to enhance their home health care segment. These strategic moves aim to support long-term growth, despite the recent stock decline.
Technical Picture
From a technical perspective, Extendicare's stock is trading slightly below its 50-day moving average of C$35.08, indicating a bearish short-term trend. The stock has a 52-week range of C$12.09 to C$39.09, currently trading at about 85% of its range. With a beta of 1.16, Extendicare's stock is slightly more volatile than the market, suggesting potential risks for investors. The latest trading volume of 474,740 shares is about 2.05 times the 20-day average volume of 379,819 shares, indicating increased trading activity.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
